Success Story: NIW Success! Iranian Postdoctoral Associate Earns Approval Through Our Tailored Approach and Team Expertise

Client’s Testimonial:

“I had a great experience working with your team and truly appreciate all the support provided throughout the process.”

On April 3^rd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Cardiovascular Physiology (Approval Notice).

General Field: Cardiovascular Physiology

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: Iran

Country of Residence at the Time of Filing: USA

Approval Notice Date: April 3^rd, 2025

Processing Time: 4 months, 21 days

Case Summary:

At North America Immigration Law Group, we are proud to celebrate another inspiring success. An accomplished Ph.D. holder from Iran, working at the intersection of molecular biology and cardiovascular physiology, recently secured approval for her I-140 NIW (National Interest Waiver) petition.

Field and Research Focus

Specializing in cardiovascular physiology, our client’s proposed endeavor involves investigating the molecular mechanisms underlying cardiovascular diseases, with the goal of translating these insights into pharmaceutical therapies.

She is currently conducting research in this field within a U.S.-based academic research environment and plans to continue publishing in high-impact journals while advancing therapeutic innovations.

Petition Category and Achievements

Filed under the EB-2 NIW category, the petition highlighted her compelling professional record:

● 11 peer-reviewed journal articles, including 4 first-authored and 1 co-first-authored, as well as 2 preprints and 8 abstracts.

● 135 total citations, including at least 4 papers ranked in the top 20% of most-cited articles in Biology & Biochemistry for their respective publication years.

● Peer reviewer for several top-ranked journals in cardiovascular medicine and physiology.

In addition to the publication record, her research has been supported by prestigious organizations, including the U.S. National Institutes of Health (NIH) and the American Heart Association (AHA) – a clear indicator of its national value and innovation.

Demonstrating National Importance

Our team demonstrated that her work holds direct relevance to U.S. public health priorities. Her research proposes new treatment paths that could:

● Minimize invasive procedures,

● Reduce national healthcare expenditures,

● Improve cardiovascular outcomes for aging populations.

Letters of Recommendation

To reinforce the strength of her case, we included 2 letters of recommendation from leading experts in her field, including one independent recommender. One letter stated:

“[Client’s] leadership in cardiovascular physiology is clearly demonstrated by her notable project outcomes and extensive record of publication. There is thus no doubt that [Client] shall continue to produce additional valuable research, both driving progress in the field and bringing immense benefits to national and international concerns.”

Outcome

With her extensive scientific contributions, strong publication metrics, and nationally significant research agenda, our client’s NIW petition was approved in 4 months and 21 days, without a request for evidence. Her case stands as an example of how meaningful, mission-driven research can be recognized and supported through the U.S. immigration system.

We are proud to have assisted this client in her immigration journey and look forward to the continued impact of her work in advancing vascular health and cardiovascular innovation in the United States.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.